The role of cholecystokinin in conditional compensatory responding and morphine tolerance in rats

Behavioral Neuroscience

Volumn 115, Issue 3, 2001, Pages 704-709

  Kim, Joseph A ^a   Siegel, Shepard ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; MORPHINE; OPIATE DERIVATIVE; PD 135158;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; HORMONE ACTION; MALE; MORPHINE TOLERANCE; NONHUMAN; RAT;

EID: 0034973155     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.115.3.704     Document Type: Article

References (35)

1. A technique for long-term blood sampling or intravenous infusion in the freely moving rat
2. Simple flow-thru swivel for infusions into unrestrained animals
3. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia
4. The assessment of and the problems involved in the experimental evaluation of narcotic analgesics
5. Alcohol is an effective cue in the conditional control of tolerance to alcohol
6. Associative and non-associative mechanisms of morphine analgesic tolerance are neurochemically distinct in the rat spinal cord
7. Route of morphine administration modulates conditioned analgesic tolerance and hyperalgesia
8. Pharmacological characterization of morphine-induced in vivo release of cholecystokinin in rat dorsal horn: Effects of ion channel blockers
9. Cholecystokinin octapeptide (CCK): A negative feedback control mechanism for opioid analgesia
10. The CCK-B receptor antagonist CI 988 reverses tolerance to morphine in rats
11. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity
12. Spinal co-administration of cholecystokinin antagonists with morphine prevents the development of opioid tolerance
13. Drug-onset cues as signals: Intra-administration associations and tolerance
14. Associative control of tolerance to the sedative effect of a short-acting benzodiazepine
15. Learning and tolerance to the ataxic effect of ethanol
16. Neurobiology, psychology and habituation
17. The cholecystokinin antagonist proglumide enhances the analgesic efficacy of morphine in humans with chronic benign pain
18. A method to perform direct transcutaneous intrathecal injection in rats
19. A locus and mechanism of action for associative morphine tolerance
20. The contribution of the rostral ventromedial medulla to the antinociceptive effects of systemic morphine in restrained and unrestrained rats
21. Tolerance to morphine analgesia is reduced by the novel addition or omission of an alcohol cue
22. Biological consequences of drug administration: Implications for acute and chronic tolerance
23. Cholecystokinin receptors in the brain: Characterization and distribution
24. Pavlovian psychopharmacology: The associative basis of tolerance
25. Cholecystokinin morphine analgesia: Variations on a theme
26. Involvement of different subtypes of cholecystokinin receptors in opioid antinociception in the mouse
27. Conditioned morphine tolerance in the rat: Absence of a compensatory response and cross-tolerance with stress
28. Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide
29. Cholecystokinin anti-analgesia: Safety cues abolish morphine analgesia
30. Cholecystokinin/opioid interactions
31. Isolation, sequencing, synthesis and pharmacological characterization of two brain neuropeptides that modulate the actions of morphine
32. Accelerated expression of cholecystokinin gene in the brain of rats rendered tolerant to morphine